Our study revealed that the mRNA expression of CDKN2A did not exhibit any significant correlation with patient age, sex, body mass index (BMI), tumor location, tumor size, depth of infiltration, peri-intestinal lymph node metastasis, distant metastasis, P53 status, or Ki67 status. The gene discussed is CDKN2A; the disease is neoplasm.